Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
European Lung Cancer Working Party
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Histological or cytological diagnosis of non-small cell carcinoma of the lung
Initially unresectable non-metastatic stage III disease
Availability for participating in the detailed follow-up of the protocol
Presence of an evaluable or measurable lesion
Written informed consent
No functional or anatomical contraindication to chest irradiation
You may not be if
Prior treatment with chemotherapy, radiotherapy or surgery
Performance status \< 60 on the Karnofsky scale
History of prior malignant tumour, except non-melanoma skin cancer or in situ carcinoma of the cervix or cured malignant tumour (more than 5 year disease-free interval)
Neutrophils \< 2,000/mm³
Platelet cells \< 100,000/mm3
Serum bilirubin \> 1.5 mg/100 ml
Hepatic disease contra-indicating the administration of docetaxel and/or GOT or GPT ≥ 2.5x the normal value and/or alkaline phosphatase ≥ 5x the normal value
